Trial Profile
Safety and efficacy of photodynamic therapy using ME2906 and PNL6405GST for gastric cancer in patients who cannot undergo surgery or endoscopic resection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2022
Price :
$35
*
At a glance
- Drugs Photosensitisers (Primary) ; Talaporfin (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 24 May 2022 Status changed from recruiting to completed.
- 21 Sep 2018 Status changed from not yet recruiting to recruiting.
- 02 May 2018 New trial record